Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Traumatic Injuries in Sexual Assault Patients in the Emergency Department.

The western journal of emergency medicine·2022
Same author

Quality control of image sensors using gaseous tritium light sources.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2022
Same author

New Approaches to SCLC Therapy: From the Laboratory to the Clinic.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2020
Same author

Sexually Transmitted Infections.

Emergency medicine clinics of North America·2019
Same author

Paraganglioma of the spermatic cord: A case report and literature review.

International journal of surgery case reports·2019
Same author

Perspectives and implications of the new sepsis clinical practice guidelines.

Journal of thoracic disease·2016

Related Experiment Video

Updated: May 27, 2026

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
07:20

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery

Published on: February 28, 2020

Pterostilbene and cancer: current review.

Denise McCormack1, David McFadden

  • 1Department of Surgery, Danbury Hospital, Danbury, Connecticut 06810, USA. Denise.McCormack@wcthealthnetwork.org

The Journal of Surgical Research
|November 22, 2011
PubMed
Summary

Pterostilbene, an antioxidant from blueberries, shows promise as an anticancer agent by inhibiting cancer growth and metastasis in preclinical studies. Its higher bioavailability and antioxidant effects warrant further investigation into human pharmacological mechanisms.

More Related Videos

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Related Experiment Videos

Last Updated: May 27, 2026

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
07:20

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery

Published on: February 28, 2020

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Area of Science:

  • Nutritional Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Pterostilbene (trans-3,5-dimethoxy-4-hydroxystilbene) is a naturally occurring antioxidant found in blueberries.
  • It possesses antineoplastic properties suggesting potential as an anticancer agent.
  • Preliminary data indicates superior bioavailability compared to other stilbenes.

Purpose of the Study:

  • To comprehensively review the antineoplastic mechanisms of pterostilbene.
  • To summarize preclinical findings on pterostilbene's anticancer effects.
  • To highlight recent advancements in pterostilbene research.

Main Methods:

  • Review of in vitro studies examining pterostilbene's effects on cancer cell lines.
  • Analysis of in vivo studies investigating pterostilbene's impact on tumorigenesis and metastasis.
  • Evaluation of preclinical data on pterostilbene's antioxidant capacity and bioavailability.

Main Results:

  • In vitro: Pterostilbene inhibits cancer cell cycle progression, induces apoptosis, and suppresses metastasis.
  • In vivo: Pterostilbene demonstrates inhibition of tumorigenesis and metastasis with minimal toxicity.
  • Pterostilbene enhances antioxidant capacity in cancer cells, potentially contributing to its anticarcinogenic function.

Conclusions:

  • Pterostilbene exhibits significant antineoplastic potential through multiple mechanisms.
  • Its favorable bioavailability and antioxidant properties make it a promising dietary compound for cancer research.
  • Further investigation into the pharmacological mechanisms and human effects of pterostilbene is warranted.